CoChat

Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)

Open access
Zarin, Deborah A., Tse, Tony · 2016 · PLOS Medicine
Cited by 53

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The Institute of Medicine (IOM) [1], journal editors [2,3], and many others [4][5][6] have called for more widespread, third-party access to the individual participant data (IPD) and associated documentation from clinical trials (i.e., "IPD sharing").Advocates assert that access to trial IPD will help to address well-established flaws in the current system of communicating trial results, including nonpublication, selective reporting, and lack of reproducibility [7].Additional proposed benefits include the ability to reanalyze study data (e.g., validation and/or correction of previously published findings [8]) and to combine data from multiple studies (e.g., IPD-level meta-analyses [9]).Others note the burdens and costs associated with preparing IPD and associated documentation for sharing, the need to ensure participant privacy, and the risk of invalid analyses [10].We do not attempt to replicate the more comprehensive analysis of IPD sharing that was conducted by the recent IOM panel [1].However, we believe that it would be helpful at this pivotal time to consider the implications of IPD sharing within the context of the "trial reporting system" (TRS), which encompasses existing efforts to enhance access to information about trials and their findings and to improve the transparency of the clinical research enterprise (CRE) [11].In this essay, we attempt to add precision to the ongoing discussion by examining the range of information granularity associated with different types of IPD.We then consider IPD sharing within a three-level TRS framework and illustrate the roles of these levels with a case study. Summary Points• The role of individual participant data (IPD) sharing can best be understood as part of an overall three-level trial reporting system (TRS) framework.• Different "types" of IPD, which reflect varying degrees of information granularity, have different potential benefits and harms.• Study 329 of Paxil (paroxetine) in children with depression is used as a case study to highlight the potential value of different components of the TRS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1001946

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 53

Metadata

Authors
Zarin, D. A., & Tse, T.
Venue
PLOS Medicine
Published
2016-01-19
Volume
13
Issue
1
Pages
e1001946
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2273468966
Cited by
53
References
4
FWCI
18.58
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS). https://app.cochat.ai/papers/10.1371/journal.pmed.1001946
The paper
Zarin, D. A., & Tse, T. (2016). Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS). PLOS Medicine. https://doi.org/10.1371/journal.pmed.1001946

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.